The power of highly innovative, cutting-edge research in genetics can transform patients’ futures. A key part of advancing this important work is the creation of the new $50 million Roberts Collaborative for Genetics and Individualized Medicine at Children’s Hospital of Philadelphia.
Sometimes in medicine, it’s all about the way you look at things. Not noticing a subtle finding on an X-ray, for instance, can result in a missed or delayed diagnosis. On the other hand, radiology overcalls can lead to unnecessary treatments.
If a cancer cell were an enemy spaceship in a science fiction movie, defeating it would be pretty easy: Just look for the big red self-destruct button and manipulate someone inside into pressing it.
If you could hire sick children as mystery shoppers, you could learn a lot about care quality and variability in the health system. Imagine sending a child with a common ailment, such as an ear infection, to see a series of unwitting pediatricians, then comparing their performance.
One of the biggest obstacles to advancing the development of therapies for pediatric rare diseases is that oftentimes we do not fully understand how a certain condition progresses in individuals over time. It is like driving someplace with a stalled navigation app and not knowing where to head beyond the next few turns.
A lot could go wrong in a clinical trial for cancer, even for a treatment that proves effective.
From the 1990s to today, a lot has changed. Babies born in that decade are now older adolescents and young adults. “Personal digital assistants” disappeared and were replaced with voice-activated intelligent helpers in our cell phones. Plaid went out of style and then came back again.
As you’re driving down the expressway, your cell phone pings, and you glance down at an incoming text message from your best friend. Next thing you know, your car slams the guardrail. The crash leaves you with a severe concussion and a serious lesson learned about distracted driving.